Modeling Kaempferol as a Potential Pharmacological Agent for COVID-19/PF Co-Occurrence Based on Bioinformatics and System Pharmacological Tools

• Main Authors: Yong Jiang (Author), Yi-Zi Xie (Author), Chen-Wen Peng (Author), Kai-Nan Yao (Author), Xue-Ying Lin (Author), Shao-Feng Zhan (Author), Hong-Fa Zhuang (Author), Hui-Ting Huang (Author), Xiao-Hong Liu (Author), Xiu-Fang Huang (Author), Hang Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: People suffering from coronavirus disease 2019 (COVID-19) are prone to develop pulmonary fibrosis (PF), but there is currently no definitive treatment for COVID-19/PF co-occurrence. Kaempferol with promising antiviral and anti-fibrotic effects is expected to become a potential treatment f...